Table I.
Subjects' demographics and baseline characteristics
| AHBVIT group | SHBVIT group | P value | |
|---|---|---|---|
| Demographics | |||
| No. of subjects | 16 | 10 | |
| Mean age (y) | 40 | 46 | .14 |
| Male sex (no.) | 11 | 9 | |
| Hypertension | 2 | 0 | |
| Past medical history of malignancy | 1 | 0 | |
| Current smoker | 6 | 1 | |
| General allergy history | |||
| Rhinitis | 1 | 1 | |
| Asthma | 4 | 2 | |
| Non–sting-induced anaphylaxis | 3 | 1 | |
| Bee sting history (baseline) | |||
| Grade of worst honeybee reaction | |||
| 1 | 1 | 0 | |
| 2 | 10 | 5 | .29 |
| 3 | 5 | 5 | |
| Baseline MCT (μg/L) | |||
| Mean | 5.8 | 7.9 | .70 |
| Range | 2-12 | 4-19 | |
| No. >12 μg/L | 0 | 3 | |
| Positive honeybee venom skin test responses per concentration tested | |||
| 0.001 | 2 | 0 | |
| 0.01 | 3 | 3 | |
| 0.1 | 4 | 3 | |
| 1 | 4 | 3 | |
| Total IgE (kU/mL) | |||
| Mean | 275 | 161 | .82 |
| Range | 18-1804 | 7-299 | |
| Honey bee–specific IgE (kU/mL) | |||
| Mean | 22.5 | 10.2 | .20 |
| Range | 0.74-87.9 | 2.6-38 |